Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.
Pixberg C, Zapatka M, Hlevnjak M, Benedetto S, Suppelna JP, Heil J, Smetanay K, Michel L, Fremd C, Körber V, Rübsam M, Buschhorn L, Heublein S, Schäfgen B, Golatta M, Gomez C, von Au A, Wallwiener M, Wolf S, Dikow N, Schaaf C, Gutjahr E, Allgäuer M, Stenzinger A, Pfütze K, Kirsten R, Hübschmann D, Sinn HP, Jäger D, Trumpp A, Schlenk R, Höfer T, Thewes V, Schneeweiss A, Lichter P. Pixberg C, et al. Among authors: heublein s. ESMO Open. 2022 Dec;7(6):100637. doi: 10.1016/j.esmoop.2022.100637. Epub 2022 Nov 21. ESMO Open. 2022. PMID: 36423362 Free PMC article. Clinical Trial.
Time trends of neoadjuvant chemotherapy for early breast cancer.
Riedel F, Hoffmann AS, Moderow M, Heublein S, Deutsch TM, Golatta M, Wallwiener M, Schneeweiss A, Heil J, Hennigs A. Riedel F, et al. Among authors: heublein s. Int J Cancer. 2020 Dec 1;147(11):3049-3058. doi: 10.1002/ijc.33122. Epub 2020 Jun 13. Int J Cancer. 2020. PMID: 32468577 Free article.
Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008-2017.
Riedel F, Hoffmann AS, Moderow M, Feisst M, Heublein S, Deutsch TM, Schäfgen B, Golatta M, Domschke C, Wallwiener M, Heil J, Hennigs A. Riedel F, et al. Among authors: heublein s. Breast. 2021 Aug;58:63-71. doi: 10.1016/j.breast.2021.04.006. Epub 2021 Apr 23. Breast. 2021. PMID: 33933924 Free PMC article.
Impact of age on indication for chemotherapy in early breast cancer patients: results from 104 German institutions from 2008 to 2017.
Hoffmann AS, Hennigs A, Feisst M, Moderow M, Heublein S, Deutsch TM, Togawa R, Schäfgen B, Wallwiener M, Golatta M, Heil J, Riedel F. Hoffmann AS, et al. Among authors: heublein s. Arch Gynecol Obstet. 2023 Jul;308(1):219-229. doi: 10.1007/s00404-022-06902-9. Epub 2023 Jan 5. Arch Gynecol Obstet. 2023. PMID: 36604331 Free PMC article.
Endometrial hyperplasia as a risk factor of endometrial cancer.
Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M. Nees LK, et al. Among authors: heublein s. Arch Gynecol Obstet. 2022 Aug;306(2):407-421. doi: 10.1007/s00404-021-06380-5. Epub 2022 Jan 10. Arch Gynecol Obstet. 2022. PMID: 35001185 Free PMC article. Review.
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Krämer P, Talhouk A, Brett MA, Chiu DS, Cairns ES, Scheunhage DA, Hammond RFL, Farnell D, Nazeran TM, Grube M, Xia Z, Senz J, Leung S, Feil L, Pasternak J, Dixon K, Hartkopf A, Krämer B, Brucker S, Heitz F, du Bois A, Harter P, Kommoss FKF, Sinn HP, Heublein S, Kommoss F, Vollert HW, Manchanda R, de Kroon CD, Nijman HW, de Bruyn M, Thompson EF, Bashashati A, McAlpine JN, Singh N, Tinker AV, Staebler A, Bosse T, Kommoss S, Köbel M, Anglesio MS. Krämer P, et al. Among authors: heublein s. Clin Cancer Res. 2020 Oct 15;26(20):5400-5410. doi: 10.1158/1078-0432.CCR-20-1268. Epub 2020 Jul 31. Clin Cancer Res. 2020. PMID: 32737030
70 results